Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Drug or tool, design or serendipity?

Iterative protein structure-based ligand design has led to a ‘selective’ inhibitor of human non-pancreatic secretory phospholipase A2 which provides a new tool for probing metabolic pathways and may lead to a useful drug.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Cintron, I. Chemical marketing Reporter 243(No. 11), 7–10 (1993).

    Google Scholar 

  2. Glaser, K.B. Adv. Pharmacol. 32, 31–66 (1995).

    Article  CAS  Google Scholar 

  3. Schevitz, R.W. et al. Nature struct. Biology 2, 458–465 (1995).

    Article  CAS  Google Scholar 

  4. Mobilio, D. & Marshall, L.A. A. Rep. med. Chem. 24, 157–166 (1989).

    CAS  Google Scholar 

  5. Clark, J.D. et al. Proc. natn. Acad. Sci. U.S.A. 88, 5418–5422 (1991).

    Article  CAS  Google Scholar 

  6. Vadas, P., Browning, J., Edelson, J. & Pruzanski, W.J. Lipid Mediators 8, 1–30 (1993).

    CAS  Google Scholar 

  7. Kuntz, I.D. Science 257, 1078–1082 (1992).

    Article  CAS  Google Scholar 

  8. Gelb, M.H., Jain, M.K. & Berg, O.G. FASEB J. 8, 916–924 (1994).

    Article  CAS  Google Scholar 

  9. Kaplan, L., Weiss, J. & Elsbach, P. Proc. Natn. Acad. Sci. U.S.A. 75, 2955–2958 (1978).

    Article  CAS  Google Scholar 

  10. Shen, T.-Y., et al. J. Am. chem. Soc. 85, 488–489 (1963).

    Article  CAS  Google Scholar 

  11. Shen, T.-Y. & Winter, C.A. Adv. drug Res. 12, 89–245 (1977).

    Article  CAS  Google Scholar 

  12. Reynolds, L.J., Hughes, L.L. & Dennis, E.A. Anal. Biochem. 204, 190–197 (1992).

    Article  CAS  Google Scholar 

  13. Wery, J.-P., et al. Nature 352, 79–82 (1991).

    Article  CAS  Google Scholar 

  14. Scott, D.L. et al. Science 254, 1007–1010 (1991).

    Article  CAS  Google Scholar 

  15. Verlinde, C.L.M.J. & Hol, W.G.J. Structure 2, 577–587 (1994).

    Article  CAS  Google Scholar 

  16. Thunnissen, M.M.G.M. et al. Nature 347, 689–691 (1990).

    Article  Google Scholar 

  17. Banner, D., et al. in Perspectives in Medicinal Chemistry. Proceedings oftheXlllth International Symposium on Medicinal Chemistry, 22–43 (Verlag Chimica Acta. Basel).

  18. Mattos, C., Rasmussen, B., Ding, X., Petsko, G.A. & Ringe, D. Nature struct. Biol. 1, 55–58 (1994).

    Article  CAS  Google Scholar 

  19. BIOGRAF 3.21, Molecular Simulations, Inc., Burlington, MA, USA.

  20. Dijkstra, B.W., Renetseder, R., Kalk, K.H., Hol, W.G.J. & Drenth, J. J.molec. Biol. 168, 163–179 (1983).

    Article  CAS  Google Scholar 

  21. Connolly, S . & Robinson, D.H. Curr. Opin. ther Patents, 1141–1155 (1993).

  22. West, M.L. & Fairlie, D.P. Trends pharmacol. Sci. 16, 67–75 (1995).

    Article  CAS  Google Scholar 

  23. Nicholls, A. & Honig, B. GRASP, Columbia University, New York.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verlinde, C., Dijkstra, B. Drug or tool, design or serendipity?. Nat Struct Mol Biol 2, 429–432 (1995). https://doi.org/10.1038/nsb0695-429

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nsb0695-429

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing